In patients without diabetes mellitus, a benefit on pneumonia rates was seen with both ACE inhibitors (adjusted OR 0.67, 95% CI 0.50 to.89) and ARBs (adjusted OR 0.49, 95% CI 0.32 to 0.75). This evidence concerns the gene ACE and pneumonia.